CVS Health Corp. planned insider sales
In the last twelve months insiders at CVS Health Corp. filed 3 Form 144 notices of planned sales, 74,631 shares worth $6.7 million at the time of filing, from 3 sellers. The latest, filed 22 May 2026: Aguirre Fernando (director), 2,263 shares worth $214,283, planned for around 20 May 2026 through TD Securities (USA) LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 22 May 2026 | Aguirre Fernando | Director | 2,263 | $214,283 | 20 May 2026 | No matching Form 4 sale | TD Securities (USA) LLC | Compensation | Form 144 |
| 21 May 2026 | Farah Roger N | Director | 2,817 | $263,886 | 21 May 2026 | No matching Form 4 sale | Charles Schwab Corp. | Compensation | Form 144 |
| 8 May 2026 | Tilak Mandadi | Officer | 69,551 | $6.2 million | 8 May 2026 | 69,551 shares from 8 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.